259 related articles for article (PubMed ID: 32423277)
1. Patient Inspiratory Maneuver Performance; Peak Lungpower, Acceleration and Volume.
Haikarainen J; Vahteristo M; Lähelmä S; Vartiainen V; Malmberg LP
J Aerosol Med Pulm Drug Deliv; 2020 Dec; 33(6):305-313. PubMed ID: 32423277
[No Abstract] [Full Text] [Related]
2. The inhalation characteristics of patients when they use different dry powder inhalers.
Azouz W; Chetcuti P; Hosker HS; Saralaya D; Stephenson J; Chrystyn H
J Aerosol Med Pulm Drug Deliv; 2015 Feb; 28(1):35-42. PubMed ID: 24815999
[TBL] [Abstract][Full Text] [Related]
3. Peak inspiratory flow rate and slope of the inhalation profiles in dry powder inhalers.
Broeders ME; Molema J; Vermue NA; Folgering HT
Eur Respir J; 2001 Nov; 18(5):780-3. PubMed ID: 11757627
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of in vitro and in vivo flow rate dependency of budesonide/formoterol Easyhaler(®).
Malmberg LP; Everard ML; Haikarainen J; Lähelmä S
J Aerosol Med Pulm Drug Deliv; 2014 Oct; 27(5):329-40. PubMed ID: 24978441
[TBL] [Abstract][Full Text] [Related]
5. [The variability of peak inspiratory flow (PIF) on valves imitating dry powder inhalers resistance during asthma and COPD exacerbations].
Grabowski M; Barg W; Chmielowicz B; Kopeć A; Panaszek B
Pneumonol Alergol Pol; 2007; 75(4):324-30. PubMed ID: 18080981
[TBL] [Abstract][Full Text] [Related]
6. Inhalation profiles in asthmatics and COPD patients: reproducibility and effect of instruction.
Broeders ME; Molema J; Hop WC; Folgering HT
J Aerosol Med; 2003; 16(2):131-41. PubMed ID: 12823907
[TBL] [Abstract][Full Text] [Related]
7. Assessment of satisfaction with different dry powder inhalation devices in Greek patients with COPD and asthma: the ANASA study.
Zervas E; Samitas K; Gaga M
Int J Chron Obstruct Pulmon Dis; 2016; 11():1845-55. PubMed ID: 27540287
[TBL] [Abstract][Full Text] [Related]
8. High inhaler resistance does not limit successful inspiratory maneuver among patients with asthma or COPD.
Vartiainen VA; Lavorini F; Murphy AC; Rabe KF
Expert Opin Drug Deliv; 2023 Mar; 20(3):385-393. PubMed ID: 36820500
[TBL] [Abstract][Full Text] [Related]
9. Patients with asthma or chronic obstructive pulmonary disease (COPD) can generate sufficient inspiratory flows via Easyhaler
Malmberg LP; Pelkonen AS; Vartiainen V; Vahteristo M; Lähelmä S; Jõgi R
J Thorac Dis; 2021 Feb; 13(2):621-631. PubMed ID: 33717535
[TBL] [Abstract][Full Text] [Related]
10. Practical problems with aerosol therapy in COPD.
Rau JL
Respir Care; 2006 Feb; 51(2):158-72. PubMed ID: 16441960
[TBL] [Abstract][Full Text] [Related]
11. Assessment of the Power Required for Optimal Use of Current Inhalation Devices.
Pohlmann G; Hohlfeld JM; Haidl P; Pankalla J; Cloes RM
J Aerosol Med Pulm Drug Deliv; 2018 Dec; 31(6):339-346. PubMed ID: 29791260
[No Abstract] [Full Text] [Related]
12. Inspiratory flow profile and usability of the NEXThaler, a multidose dry powder inhaler, in asthma and COPD.
Chetta A; Yorgancioglu A; Scuri M; Barile S; Guastalla D; Dekhuijzen PNR
BMC Pulm Med; 2021 Feb; 21(1):65. PubMed ID: 33632183
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and factors associated with suboptimal peak inspiratory flow rates in COPD.
Ghosh S; Pleasants RA; Ohar JA; Donohue JF; Drummond MB
Int J Chron Obstruct Pulmon Dis; 2019; 14():585-595. PubMed ID: 30880948
[TBL] [Abstract][Full Text] [Related]
14. Inspiratory flow rates at different levels of resistance in elderly COPD patients.
Janssens W; VandenBrande P; Hardeman E; De Langhe E; Philps T; Troosters T; Decramer M
Eur Respir J; 2008 Jan; 31(1):78-83. PubMed ID: 17898020
[TBL] [Abstract][Full Text] [Related]
15. Comparison of peak inspiratory flow rate via the Breezhaler®, Ellipta® and HandiHaler® dry powder inhalers in patients with moderate to very severe COPD: a randomized cross-over trial.
Altman P; Wehbe L; Dederichs J; Guerin T; Ament B; Moronta MC; Pino AV; Goyal P
BMC Pulm Med; 2018 Jun; 18(1):100. PubMed ID: 29898702
[TBL] [Abstract][Full Text] [Related]
16. Novolizer: how does it fit into inhalation therapy?
Magnussen H
Curr Med Res Opin; 2005; 21 Suppl 4():S39-46; discussion S47. PubMed ID: 16138944
[TBL] [Abstract][Full Text] [Related]
17. In Vitro Flow Rate Dependency of Delivered Dose and Fine Particle Dose of Salmeterol/Fluticasone Propionate Easyhaler and Seretide Diskus with Patient Flow Rates Collected in a Randomized Controlled Trial.
Jõgi R; Lähelmä S; Vahteristo M; Happonen A; Haikarainen J
J Aerosol Med Pulm Drug Deliv; 2019 Apr; 32(2):88-98. PubMed ID: 30300557
[TBL] [Abstract][Full Text] [Related]
18. The course of inhalation profiles during an exacerbation of obstructive lung disease.
Broeders ME; Molema J; Hop WC; Vermue NA; Folgering HT
Respir Med; 2004 Dec; 98(12):1173-9. PubMed ID: 15588037
[TBL] [Abstract][Full Text] [Related]
19. Inspiratory flows through dry powder inhaler in chronic obstructive pulmonary disease: age and gender rather than severity matters.
Malmberg LP; Rytilä P; Happonen P; Haahtela T
Int J Chron Obstruct Pulmon Dis; 2010 Aug; 5():257-62. PubMed ID: 20714380
[TBL] [Abstract][Full Text] [Related]
20. Ventolin Diskus and Inspyril Turbuhaler: an in vitro comparison.
Broeders ME; Molema J; Burnell PK; Folgering HT
J Aerosol Med; 2005; 18(1):74-82. PubMed ID: 15741776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
